IBOV 169,277.30 ▼ 0.32% IPC MEX 70,388.96 ▼ 1.15% MERVAL 2,848,945 — — USD/BRL5.80▲ 0.37% USD/MXN18.62▲ 1.08% USD/CLP1,001▲ 0.83% USD/COP3,312▼ 0.16% USD/PEN3.41▲ 0.05% USD/ARS1,558▲ 0.37% USD/UYU40.61▲ 3.30% USD/PYG6,212▲ 3.32% USD/BOB11.64▲ 3.07% USD/DOP60.14▼ 0.27% USD/CRC441.73▲ 2.50% USD/GTQ7.64▲ 3.28% USD/HNL26.89▼ 0.10% USD/NIO36.62▲ 0.34% USD/VES913.46▼ 0.22% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.39▲ 2.57% USD/TTD6.70▲ 1.98% EUR/BRL6.36▲ 0.03% BRENT 89.38 ▼ 4.04% WTI 83.39 ▼ 3.05% IRON ORE 161.91 — — COPPER 5.67 ▼ 5.07% GOLD 3,769 ▼ 2.47% SILVER 45.24 ▼ 4.34% SOY 1,225 ▼ 0.08% CORN 444.25 ▼ 0.56% WHEAT 600.50 ▲ 0.88% COFFEE 276.75 ▼ 3.44% SUGAR 18.10 ▼ 0.39% ORANGE JUICE 132.90 ▼ 1.56% COTTON 80.95 ▲ 4.69% COCOA 5,040 ▲ 0.20% BEEF 218.60 ▼ 0.08% CATTLE 336.33 ▲ 0.22% LITHIUM 55.72 ▼ 1.24% PETR4 43.23 ▼ 1.71% VALE3 59.22 ▼ 1.86% ITUB4 40.82 ▼ 0.17% BBDC4 14.40 ▼ 0.07% ABEV3 16.07 ▲ 0.88% BBAS3 14.55 ▼ 0.48% B3SA3 14.38 ▼ 1.84% WEGE3 51.89 ▲ 1.45% PRIO3 62.95 ▼ 1.58% SUZB3 55.89 ▲ 0.90% RENT3 30.03 ▲ 1.25% AZZA3 16.25 ▲ 3.90% CSAN3 3.25 — 0.00% RAIZ4 18.49 ▼ 3.24% PCAR3 3.11 ▲ 7.61% GMAT3 4.19 ▲ 0.24% PSSA3 45.65 ▼ 0.59% CVCB3 0.78 — 0.00% POSI3 3.21 ▲ 2.56% SLCE3 18.14 ▲ 0.44% NATU3 4.85 ▲ 2.11% BRKM5 2.66 ▼ 3.27% RANI3 8.16 ▼ 0.73% CSNA3 3.85 ▲ 2.12% IBOV 169,277.30 ▼ 0.32% IPC MEX 70,388.96 ▼ 1.15% MERVAL 2,848,945 — — USD/BRL 5.79 ▲ 0.20% USD/MXN 18.60 ▲ 1.00% USD/CLP 1,001 ▲ 0.83% USD/COP 3,314 ▼ 0.09% USD/PEN 3.41 ▲ 0.05% USD/ARS 1,557 ▲ 0.31% USD/UYU 40.61 ▲ 3.30% USD/PYG 6,212 ▲ 3.32% USD/BOB 11.64 ▲ 3.07% USD/DOP 60.14 ▼ 0.27% USD/CRC 441.73 ▲ 2.50% USD/GTQ 7.64 ▲ 3.28% USD/HNL 26.89 ▼ 0.10% USD/NIO 36.62 ▲ 0.34% USD/VES 913.46 ▼ 0.22% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.39 ▲ 2.57% USD/TTD 6.70 ▲ 1.98% EUR/BRL 6.36 ▲ 0.06% BRENT 89.38 ▼ 4.04% WTI 83.39 ▼ 3.05% IRON ORE 161.91 — — COPPER 5.67 ▼ 5.07% GOLD 3,769 ▼ 2.47% SILVER 45.24 ▼ 4.34% SOY 1,225 ▼ 0.08% CORN 444.25 ▼ 0.56% WHEAT 600.50 ▲ 0.88% COFFEE 276.75 ▼ 3.44% SUGAR 18.10 ▼ 0.39% ORANGE JUICE 132.90 ▼ 1.56% COTTON 80.95 ▲ 4.69% COCOA 5,040 ▲ 0.20% BEEF 218.60 ▼ 0.08% CATTLE 336.33 ▲ 0.22% LITHIUM 55.72 ▼ 1.24% PETR4 43.23 ▼ 1.71% VALE3 59.22 ▼ 1.86% ITUB4 40.82 ▼ 0.17% BBDC4 14.40 ▼ 0.07% ABEV3 16.07 ▲ 0.88% BBAS3 14.55 ▼ 0.48% B3SA3 14.38 ▼ 1.84% WEGE3 51.89 ▲ 1.45% PRIO3 62.95 ▼ 1.58% SUZB3 55.89 ▲ 0.90% RENT3 30.03 ▲ 1.25% AZZA3 16.25 ▲ 3.90% CSAN3 3.25 — 0.00% RAIZ4 18.49 ▼ 3.24% PCAR3 3.11 ▲ 7.61% GMAT3 4.19 ▲ 0.24% PSSA3 45.65 ▼ 0.59% CVCB3 0.78 — 0.00% POSI3 3.21 ▲ 2.56% SLCE3 18.14 ▲ 0.44% NATU3 4.85 ▲ 2.11% BRKM5 2.66 ▼ 3.27% RANI3 8.16 ▼ 0.73% CSNA3 3.85 ▲ 2.12%
since 2009
Wednesday, November 18, 2026

Covid-19 Brazil

Butantan “Project S” shows pandemic can be controlled if 75% of population is vaccinated

By · · 3 min read

RIO DE JANEIRO, BRAZIL – The coronavirus pandemic can be controlled if 75% of the population is vaccinated against Covid-19, according to a study carried out in a Brazilian city, where its inhabitants were massively immunized with the CoronaVac vaccine from the Chinese laboratory Sinovac, the Butantan Institute reported this Monday, May 31.

According to the study, the first of its kind to be carried out in the world, deaths fell by 95% after mass vaccination, hospitalizations dropped by 86%, and symptomatic cases were reduced by 80%.

Pandemic can be controlled if 75% of the population is vaccinated, says Brazilian study
Pandemic can be controlled if 75% of the population is vaccinated, says a Brazilian study.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

The experiment also revealed that minors would not need to be immunized, because of the indirect effects of the vaccine.

The project took place in Serrana, a town located near Ribeirão Preto, some 200 km north of the state capital and home to 45,000 inhabitants, of whom about 30,000 over 18 years of age were immunized with the Chinese vaccine between February 17 and April 11.

Serrana was chosen for the study because it is a low-population city with high rates of Covid-19 infection.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “US Embassy warns Americans of Colombia strike Thursday”

One and a half months after the completion of the vaccination process in Serrana, the Butantan Institute, one of the most prestigious medical research centers in Brazil and Latin America, linked to the government of São Paulo and in charge of the manufacture of the Coronavac vaccine in Brazil, presented the conclusions on Monday at a press conference.

The so-called “Project S” (Serrana Project) vaccination process lasted four weeks, and in each of them, a group of adults was immunized. Control of the pandemic in the municipality was achieved when 75% of its population received the two doses of the Chinese immunizer, the study concluded.

Those responsible for the study compared the data from the beginning of the project – until the vaccination of all groups was completed – with the rest of the evaluated quarter (February, March, and April 2021).

The data show that on February 16, one day before the mass vaccination process, this municipality had 57 deaths and 2,499 confirmed cases of the virus.

After immunization, cases dropped to 699 in March and 251 in April. Deaths plummeted from 30 to 6 in the same period.

The results also showed that the vaccination protects both adults who received the two doses of the Chinese immunizer and children and adolescents under 18 years of age who were not vaccinated.

As explained by the director of clinical trials of the Butantan Institute, Ricardo Palacios, the immunization generated a sort of “immune belt” in Serrana, “drastically reducing” the transmission of the virus in the municipality.

“The most important result was to understand that we can control the pandemic even without vaccinating the entire population. When 70% to 75% coverage was reached, the drop in incidence was noticed even in the last group that had not yet completed the vaccination schedule,” he said. “It will not be necessary to vaccinate minors,” he specified.

For the general director of the Butantan Institute, Dimas Covas, this shows that the CoronaVac vaccine “is safe, effective and efficient” and contributes to preventing the development of the disease, complications, and deaths among those infected.

“We now also know that it has a beneficial effect on the entire population, protecting both vaccinated and unvaccinated people and significantly reducing viral circulation,” he added.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.